Takata Airbag
The Takata airbag MDL was centralized in February 2015 to coordinate claims arising from defective ammonium-nitrate-based airbag inflators that could, particularly after prolonged exposure to heat and humidity, rupture violently and expel metal fragments into the passenger compartment, a defect that triggered one of the largest automotive recalls in history and implicated numerous automakers as co-defendants alongside Takata itself. With 78 actions still pending, this docket reflects a mature litigation with a well-established defect record, layered against Takata's own corporate bankruptcy, which restructured how claims against the manufacturer are pursued and administered.
What drives resolution risk for any case still open in this docket is not a live scientific dispute over whether the inflator design was defective — that question was substantially resolved through the recall itself, regulatory findings, and extensive prior litigation and settlement activity — but rather the structural complexity created by the corporate-bankruptcy overlay and the multi-defendant automaker structure. A given claim's resolution path depends on which automaker's vehicle was involved, what that automaker's own settlement posture has been, and how a claim against Takata's successor entity interacts with the bankruptcy's claims-administration framework.
This multi-layered defendant and bankruptcy structure is a distinct duration-risk driver from a single-manufacturer drug or device MDL: rather than one settlement-fund timeline governing the whole docket, resolution paths can diverge significantly by automaker and by whether a claim was filed before or after key bankruptcy milestones.
Criterica Intelligence treats this kind of multi-defendant, bankruptcy-adjacent structure as its own distinct risk pattern within regulated outcomes intelligence — duration and resolution risk here are less about an open scientific question and more about navigating a genuinely complex procedural architecture, and the platform's structural reads are built to surface exactly that kind of distinction across the active MDL landscape.
It consolidates claims that Takata's ammonium-nitrate-based airbag inflators could rupture and expel metal fragments during deployment, a defect that triggered a massive recall across numerous automakers and led to Takata's own corporate bankruptcy.
Takata's bankruptcy restructured how claims against the manufacturer are administered, meaning a case's resolution path can depend on whether it proceeds against Takata's successor entity, against an automaker co-defendant, or through the bankruptcy's claims mechanism.
No — the inflator defect was substantially established through the recall itself, regulatory findings, and years of prior litigation; what remains contested in individual cases is largely defendant-specific and procedural rather than the core defect theory.
It proceeds toward trial against whichever defendant structure applies to that claim, informed by the extensive defect and recall record already established, rather than reopening the underlying causation question.
Statistics shown reflect historical or illustrative model outputs derived from real case data. They are not predictions or guarantees of any individual outcome. Litigation results depend on facts, jurisdiction, judge, and counsel, and vary case by case. Model accuracy is subject to selection effects and changing legal dynamics.